[Treatment results of patients with mitral valve disease in IV functional class of NYHA. II: Conservative treatment].
In the group of 60 patients with mitral valve disease (67% in IV and 33% in III functional class of NYHA) the efficacy of medical treatment was analysed. In all of them clinical, noninvasive and invasive investigations were obtained. The conclusion is that survival during ca 1643 days was 15% of the patients in IV class of NYHA. The death was mostly due to severe heart failure.
Rawczyńska-Englert
I
I
I Kliniki Wad Serca Instytutu Kardiologii, Warszawie.
D000328:Adult; D000368:Aged; D005260:Female; D006349:Heart Valve Diseases / Q000401:mortality / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve; D009203:Myocardial Infarction / Q000401:mortality; D012189:Retrospective Studies; D015996:Survival Rate
Wyniki leczenia chorych z wada mitralna w IV okresie czynnościowym wg NYHA. Cześć II: Leczeni zachowawczo.